O

    Omeros Corporation (OMER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $18.79
    +0.18 (+0.97%)

    Market Cap: $1.36B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(22/40)
    Avg Surprise
    +22.41%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.03
    Range$-0.05 - $0.00
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.20-686.8%
    60d ago$-0.27-980.0%
    30d ago$-0.27-980.0%
    7d ago$-0.31-1140.0%
    Current$-0.03
    Revenue Consensus
    $37M
    Range$31M - $40M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.41
    Range$1.25 - $1.57
    2 analysts
    Revenue Consensus
    $72M
    Range$50M - $92M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.41---
    Sep 26EST
    		-$-0.03---
    Jun 26
    Reported Aug 13
    		$0.02N/A+107.41%Beat+103.8%
    Mar 26
    Reported May 13
    		$0.57$-0.39+246.15%Beat+187.7%
    Dec 25
    Reported Mar 31
    		$-0.55$-0.52-5.04%Miss+0.7%
    Sep 25
    Reported Nov 13
    		$-0.32$-0.48+33.33%Beat+50.0%
    Jun 25
    Reported Aug 14
    		$-0.53$-0.55+3.64%Beat+52.7%
    Mar 25
    Reported May 15
    		$-0.65$-0.58-12.07%Miss+13.3%
    Dec 24
    Reported Mar 31
    		$-0.55$-0.71+22.54%Beat-266.7%
    Sep 24
    Reported Nov 13
    		$-0.64$-0.77+16.88%Beat+22.0%
    Jun 24
    Reported Aug 7
    		$-1.12$-1.01-10.89%Miss-60.0%
    Mar 24
    Reported Apr 1
    		$-0.75$-0.63-19.05%Miss-19.0%
    Dec 23
    Reported Mar 26
    		$-0.15N/A+72.73%Beat-107.3%
    Sep 23
    Reported Nov 9
    		$-0.82$-0.66-24.24%Miss+5.7%
    Jun 23
    Reported Aug 9
    		$-0.70$-0.53-32.08%Miss-6.1%
    Mar 23
    Reported May 9
    		$-0.63$-0.57-10.53%Miss-18.9%
    Dec 22
    Reported Mar 13
    		$2.05$-0.57+459.65%Beat+654.1%
    Sep 22
    Reported Nov 9
    		$-0.87$-0.58-50.00%Miss-141.7%
    Jun 22
    Reported Aug 9
    		$-0.66$-0.66+0.00%Beat-43.5%
    Mar 22
    Reported May 10
    		$-0.53$-0.69+23.19%Beat+7.0%
    Dec 21
    Reported Mar 1
    		$-0.37$-0.36-2.78%Miss+38.3%
    Sep 21
    Reported Nov 9
    		$-0.36$-0.47+23.40%Beat-5.9%
    Jun 21
    Reported Aug 9
    		$-0.46$-0.55+16.36%Beat+24.6%
    Mar 21
    Reported May 10
    		$-0.57$-0.51-11.76%Miss-7.5%
    Dec 20
    Reported Mar 1
    		$-0.60$-0.69+13.04%Beat-3.4%
    Sep 20
    Reported Nov 9
    		$-0.34$-0.49+30.61%Beat-3.0%
    Jun 20
    Reported Aug 10
    		$-0.61$-0.59-3.39%Miss-110.3%
    Mar 20
    Reported May 11
    		$-0.53$-0.34-55.88%Miss-6.0%
    Dec 19
    Reported Mar 2
    		$-0.58$-0.50-16.00%Miss-176.2%
    Sep 19
    Reported Nov 12
    		$-0.33$-0.41+19.51%Beat+59.3%
    Jun 19
    Reported Aug 8
    		$-0.29$-0.44+34.09%Beat+58.6%
    Mar 19
    Reported May 9
    		$-0.50$-0.47-6.38%Miss+19.4%
    Dec 18
    Reported Mar 1
    		$-0.21N/A+74.07%Beat+38.2%
    Sep 18
    Reported Nov 8
    		$-0.81$-0.71-14.08%Miss-406.3%
    Jun 18
    Reported Aug 9
    		$-0.70$-0.62-12.90%Miss-112.1%
    Mar 18
    Reported May 10
    		$-0.62$-0.59-5.08%Miss-82.4%
    Dec 17
    Reported Mar 1
    		$-0.34$-0.17-100.00%Miss+24.4%
    Sep 17
    Reported Nov 9
    		$-0.16N/A+52.94%Beat+52.9%
    Jun 17
    Reported Aug 8
    		$-0.33$-0.37+10.81%Beat-
    Mar 17
    Reported May 10
    		$-0.34$-0.35+2.86%Beat-
    Dec 16
    Reported Mar 16
    		$-0.45$-0.56+19.64%Beat-
    Sep 16
    Reported Nov 9
    		$-0.34$-0.36+5.56%Beat-

    Key Metrics

    Valuation
    P/E Ratio-67.98EV/EBITDA149.82x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin324.90%Operating Margin0.26%
    ROE-576.00%ROIC-126.26%
    Financial Health
    Debt/Equity-0.82xInterest CoverageN/A
    Current Ratio1.95xQuick Ratio1.94x
    Trading Statistics
    Beta2.54Avg Volume2.37M
    52-Week High$19.6552-Week Low$3.94

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$18.70
    SMA 20$16.59
    SMA 50$12.83
    SMA 200$11.91
    EMA 10$18.27
    EMA 20$16.80
    EMA 50$14.26
    EMA 200$11.53

    MACD

    Line: 1.93Signal: 1.91Hist: 0.02

    ADX

    ADX: 52.8+DI: 36.7-DI: 12.2

    Aroon & PSAR

    Aroon Up84.0
    Aroon DownN/A
    PSAR$19.56

    Bollinger Bands

    Upper Band$21.77
    Lower Band$11.40
    %B Position6251%(Upper)
    Band Width0.71

    RSI (14-Day)

    Overbought
    70.8

    Momentum Oscillators

    Stoch %K88.0
    Stoch %D87.6
    Williams %R-13.5
    ROC (10d)8.2%
    Momentum1.43
    CCI (20d)60.1
    MFI (14d)73.9

    Volatility Measures

    ATR (14d)$0.97(5.2%)
    StdDev (20d)2.59
    Hist Vol102.1%(High)

    Volume Flow

    VWAP$18.58
    OBV135.6M
    AD Line-30.8M
    CMF (20d)0.294

    Volume Metrics

    Avg Vol (20d)2.4M
    Vol Ratio0.5x
    VWMA (20d)$16.86

    Pivot Points

    R3$19.78
    R2$19.47
    R1$19.04
    Pivot Point$18.73
    S1$18.30
    S2$17.99
    S3$17.56

    Advanced Oscillators

    TSI54.15
    Ultimate Osc63.1
    KST659.51

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$28.53M$9.89M$0$0$0$0$0$0$0$0N/A$0
    Cost of Revenue$798,000$587,000N/A$0$0$0N/A$0$0$0N/A$0
    Gross Profit$27.73M$9.31MN/A$0$0$0N/A$0$0$0N/A$0
    Operating Expenses$27.66M$26.73M$29.08M$26.39M$32.35M$34.97M$33.35M$35.41M$59.16M$39.03M$39.77M$48.15M
    R&D$13.80M$13.36M$19.45M$15.99M$22.01M$23.85M$23.32M$24.08M$45.35M$26.77M$28.89M$31.73M
    SG&A$13.86M$13.37M$9.63M$10.40M$10.35M$11.12M$10.04M$11.32M$13.81M$12.26M$10.88M$16.42M
    Operating Income$74,000$-17,421,000$-29,081,000$-26,392,000$-32,354,000$-34,969,000$-33,355,000$-35,407,000$-59,157,000$-39,034,000$-39,765,000$-48,153,000
    Interest Income$4.63M$1.48M$0$0$1.24M$1.12M$0$0$0$3.42M$3.43M$4.41M
    Interest Expense$9.48M$5.89M$0$0$2.98M$3.65M$8.55M$0$0$8.23M$2.95M$7.92M
    Income Before Tax$6.67M$51.31M$80.43M$-26,392,000$-25,889,000$-37,565,000$-41,910,000$-35,407,000$-59,157,000$-43,850,000$-39,287,000$-51,656,000
    Income Tax Expense$29,000$57,000$0$0$0$0$0$0$0$0$0$0
    Net Income$13.23M$56.06M$81.93M$-26,392,000$-25,424,000$-33,460,000$-25,067,000$-35,407,000$-59,157,000$-37,184,000$-9,068,000$-37,750,000
    EBITDA$13.15M$57.42M$-33,796,000$-26,187,000$-23,432,000$-34,272,000$-42,758,000$-33,939,000$-59,287,000$-38,522,000$-39,157,000$-47,465,000
    EBIT$11.52M$55.73M$-29,081,000$-26,392,000$-24,147,000$-35,034,000$-33,355,000$-35,407,000$-59,157,000$-39,034,000$-39,765,000$-48,153,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OMER

    News

    Omeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?

    Omeros Corporation (OMER) has displayed a "golden cross" technical signal, where its 50-day simple moving average crossed above its 200-day simple moving average, suggesting a potential bullish breakout. The stock has rallied 70.4% in the past four weeks and holds a Zacks Rank of #3 (Hold). Combined with positive earnings outlooks and recent analyst upgrades, this technical indicator makes OMER a stock to watch.

    Yahoo Finance•8/25/26•
    Bullish

    Why Omeros (OMER) Is Up 11.3% After Swinging To Profit And Stepping Up Capital Moves

    Omeros Corporation (OMER) shares surged by 11.3% after the company announced a swing to net income for Q2 and H1 2026, repurchased shares, filed a shelf registration for ESOP-related stock, and expanded its board. This profitability shift and capital management, including the addition of a veteran investor to the Audit Committee, are reshaping its financial profile and governance. The company's future investment narrative now focuses on YARTEMLEA's commercial success and pipeline maturation, with analysts projecting significant revenue growth and a fair value of $33.00, suggesting a 71% upside.

    Simply Wall Street•8/25/26•
    Bullish

    Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now

    Omeros (OMER) recently formed a hammer chart pattern, signaling a potential trend reversal as buying interest emerged against a downtrend. This technical indicator, combined with a 39% increase in consensus EPS estimates for the current year and a Zacks Rank #2 (Buy), suggests that the stock is poised for an upward movement. Analysts' positive revisions and the strong Zacks Rank indicate improving prospects and a likely outperformance compared to the market.

    Eastern Progress•8/22/26•
    Bullish

    Omeros director Thomas J. Cable disposes of 15,000 common shares for $276,772.50

    Omeros director Thomas J. Cable sold 15,000 common shares for $276,772.50 on August 20, 2026, at an average price of $18.45 per share. These transactions followed his exercise of two stock option tranches for the same number of shares at $2 and $3.93. As a result, his direct holdings in Omeros common shares decreased to 35,067.

    Bitget•8/22/26•
    Somewhat-Bearish

    Omeros Corp (OMER) Director Thomas Cable Sells 15,000 Shares

    Omeros Corp (OMER) Director Thomas Cable sold 15,000 shares of the company on August 20, 2026, for a total of $276,750, bringing his direct ownership to 35,067 shares. This sale is part of a year-long trend of insider selling with no insider purchases, which may be a cautionary signal for investors. The company's valuation metrics, including a P/E ratio of 15.05, suggest it may be trading at a discount compared to its industry peers but is more expensive relative to its own historical earnings.

    GuruFocus•8/22/26•
    Somewhat-Bearish

    Frequently Asked Questions About OMER

    Does OMER pay dividends?
    Omeros Corporation (OMER) does not currently pay a regular dividend.
    What is OMER's market cap?
    Omeros Corporation (OMER) has a market capitalization of $1.36B with a current stock price of $18.79.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In